510(k) Report

510(k) · Cleared

Cleared

NICO Myriad

K161307510(k) TraditionalCleared Dec 21, 2016225-day reviewClass II21 CFR 878.4400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nico Corporation · GEI Electrosurgical, Cutting & Coagulation & Accessories

Cleared on Dec 21, 2016 as substantially equivalent to K955168 (Promex, Inc., 1996) and 2 other predicates after a 225-day review. Its family tree reaches back 1 generation to 1996. 4 later devices descend from it.

Decided
Dec 21, 2016
Review
225 days
Class
Class II
Product code
GEI
Recalls
None
Predicates
3

Its longest line of descent runs back 1 generation to K955168 (1996). 3 ancestors in all. 4 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor1997: 1 other ancestor2018: 2 descendants cleared2019: 2 descendants clearedK955168 · Surgical Cutter · Promex, Inc. · 1996 · recalled1995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 2 descendants K955168 · Surgical Cutter · Promex, Inc. · 1996 · recalled0
  1. Root · 1 generation backK955168 Surgical CutterPromex, Inc. · 1996 · Recalled
  2. This deviceK161307 NICO MyriadNico Corporation · 2016
  3. Descendant · cites it directly · 1 of its ownK182340 NICO MyriadNico Corporation · 2018
  4. Descendant · cites it directly · 1 of its ownK180372 Aurora EvacuatorRebound Therapeutics · 2018
  5. Descendant · 2 generations on · 0 of its ownK191599 NICO Myriad NOVUSNico Corporation · 2019 · Recalled
  6. Descendant · 2 generations on · 0 of its ownK190075 Aurora EvacuatorRebound Therapeutics · 2019

Most influential descendants

Showing 4 of 4 · See all
  • K182340NICO MyriadNico Corporation · 2018 · cites it directly1descendant
  • K180372Aurora EvacuatorRebound Therapeutics · 2018 · cites it directly1descendant
  • K191599NICO Myriad NOVUSNico Corporation · 2019 · 2 generations on0descendants
  • K190075Aurora EvacuatorRebound Therapeutics · 2019 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K955168Surgical CutterPromex, Inc.19962
0 (this device)K161307NICO MyriadNico Corporation2016—
+1K182340NICO MyriadNico Corporation2018—
+1K180372Aurora EvacuatorRebound Therapeutics2018—
+2K191599NICO Myriad NOVUSNico Corporation20195
+2K190075Aurora EvacuatorRebound Therapeutics2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201820
201920
FIG. 1 — Lineage of K161307, 1996–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEI device

  1. #1 K231790 The InMode System with the Morpheus8 Applicatorsscore 32.7 · 21 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K955168Surgical Cutter
Summary page 4
…21 CFR § 874.4250 (Class II) Product Code: GEI Secondary Product ERL, HBC Codes: K955168, Promex Surgical Cutter, §878.4400, GEI Predicate Devices: K972865, Promex ENT Tissue Removal System, §874.4250, ERL…
Promex, Inc.19962
*K972865Promex Ent Tissue Removal System
Summary page 4
…Secondary Product ERL, HBC Codes: K955168, Promex Surgical Cutter, §878.4400, GEI Predicate Devices: K972865, Promex ENT Tissue Removal System, §874.4250, ERL K002523, Advantage Drive System, §882.4360, HBC, §878.…
Promex, Inc.1997—
*K002523Advantage Drive System
Summary page 4
…K955168, Promex Surgical Cutter, §878.4400, GEI Predicate Devices: K972865, Promex ENT Tissue Removal System, §874.4250, ERL K002523, Advantage Drive System, §882.4360, HBC, §878.4820, GEY Device Description The Myriad is a minimally invasive surgical system des…
Linvatec Corp.2000—

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K182340NICO MyriadNico Corporation20181
K180372Aurora EvacuatorRebound Therapeutics20181

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K182340 (Nico Corporation, 2018) has gone furthest, with 1 descendant of its own.

How does its category compare?

All GEI devices

GEI Electrosurgical, Cutting & Coagulation & Accessories: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · GEI

52in 2025

2007: 502008: 612009: 422010: 462011: 352012: 392013: 482014: 492015: 472016: 642017: 522018: 472019: 482020: 592021: 462022: 552023: 652024: 592025: 522026 (partial year): 43
2007high 65 (2023) · low 35 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEI

113in 2025

2007: 51 days median2008: 71 days median2009: 130 days median2010: 109 days median2011: 135 days median2012: 133 days median2013: 136 days median2014: 103 days median2015: 123 days median2016: 108 days median2017: 72 days median2018: 93 days median2019: 93 days median2020: 105 days median2021: 146 days median2022: 150 days median2023: 104 days median2024: 125 days median2025: 113 days median2026 (partial year): 183 days median
2007high 183 (2026) · low 51 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEI

4in 2025

2007: 212008: 192009: 272010: 512011: 322012: 302013: 132014: 32015: 42016: 32017: 22018: 62019: 52020: 12021: 62022: 492023: 27, 4 Class I2024: 22, 10 Class I2025: 42026 (partial year): 8
2007high 51 (2010) · low 1 (2020)2026

Class I (14 since 2007) Class II/III not classified

Adverse event reports per year · GEI

7,592in 2025

2007: 2,7952008: 2,5562009: 3,5912010: 3,3772011: 4,4632012: 5,2162013: 4,8972014: 4,9082015: 4,9362016: 5,6162017: 6,0732018: 6,5452019: 7,0672020: 6,4902021: 6,3542022: 6,1032023: 7,1762024: 7,8972025: 7,592
2007high 7,897 (2024) · low 2,556 (2008)2025

MAUDE reports naming product code GEI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075051212,795
20086171192,556
200942130273,591
201046109513,377
201135135324,463
201239133305,216
201348136134,897
20144910334,908
20154712344,936
20166410835,616
2017527226,073
2018479366,545
2019489357,067
20205910516,490
20214614666,354
202255150496,103
20236510427 (4)7,176
20245912522 (10)7,897
20255211347,592
2026431838—

What is it indicated for?

The NICO Myriad™ is a powered instrument consisting of a console, handpieces, and accessories intended to perform resection and removal of soft tissue and fluids under direct visualization. Types of direct visualization may include laparoscopic, pelviscopic, endoscopic, percutaneous, and open. Applications include those when access to the surgical site is limited, such as Neurosurgical/Spinal and ENT/Otolaryngological.

Specific neurosurgical indications may include diseases such as the following:

• Primary/Secondary Brain Tumors

• Vascular Abnormalities/Malformations (e.g., hemangiomas, cavernomas, and hematoma evacuation)

• Intraventricular Tumors/Cysts

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161307: NICO Myriad.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161307

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026